Related Experiment Video
Updated: May 2, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
31.9K
Implementing guidelines for depression on antidepressant prescribing in general practice: a quasi-experimental
Gerdien Franx1, Jochanan Huyser, Jan Koetsenruijter
1Trimbos Institute, Netherlands institute of mental health and addiction, PO Box 725, 3500 AS Utrecht, the Netherlands. gfranx@trimbos.nl.
BMC Family Practice
|February 21, 2014
Summary
Implementing a stepped care approach significantly reduced antidepressant prescribing in general practice for mild depression. This quality improvement collaborative demonstrated that general practitioners can alter prescribing habits effectively.
Area of Science:
- General Practice
- Psychiatry
- Health Services Research
Background:
- International guidelines advocate for stepped care in depression, avoiding antidepressants as a first-line treatment for mild symptoms.
- Antidepressant prescribing rates as a first treatment step in Dutch general practice are notably high.
- This study aimed to assess the implementation of guideline recommendations regarding antidepressant prescribing.
Purpose of the Study:
- To evaluate the effectiveness of a Quality Improvement Collaborative (QIC) in implementing stepped care principles for depression.
- To determine if the QIC intervention could reduce antidepressant prescription rates in general practice.
- To compare changes in prescribing behavior between intervention and control groups.
Main Methods:
- A quasi-experimental study with a non-equivalent control group was conducted over three years in Dutch general practice.
- General Practitioners (GPs) in the intervention group participated in a QIC focused on a stepped care model for depression.
- Antidepressant prescription rates were compared between GPs in the QIC and a control group from a national registration network.
Main Results:
- The intervention group showed a significant decrease of 23.3% in antidepressant prescription rates for newly diagnosed depressive symptoms (from 49.4% to 26.1%).
- The control group exhibited no significant change in antidepressant prescription rates (ranging from 50.3% to 52.6%).
- The observed decrease in the intervention group was statistically significant compared to the usual care group (OR 0.44, 95% CI: 0.21-0.92).
Conclusions:
- An implementation program based on stepped care principles successfully reduced antidepressant prescribing in general practice.
- General Practitioners demonstrated the capacity to modify their prescribing behavior through participation in a Quality Improvement Collaborative.
- The findings support the adoption of stepped care models to optimize depression treatment in primary care settings.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
744
10:54Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
1.1K
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:25Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
01:54The Placebo Effect
5.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
5.9K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
01:21G-protein Coupled Receptors
91.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
91.4K